Back to Awarded Treatment Trials
Awarded Trial: 03T-388
Grant ID
03T-388
Illness
Schizophrenia
Primary Drug/Intervention
Bezoar Xiexin Tang
Primary Dosage
60mg
Secondary Drug Intervention
N/A
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Completed
Investigator
Cai
Sample Size
200
Duration of Study Period for Each Subject
6 weeks
Outcome Measurements
PANSS, CGI
Results
There was no significant effect of the test medication over placebo.
Publication
N/A
Link
N/A
PI Name
Hongjiao Cai
Degree
MD
Center
N/A
Institution
Wuhan Dapeng Pharmaceutical Co., Ltd.
Address
152 Yanjiang Avenue
City or Town
Wuhan
State or Province
N/A
Zip or Postal Code
430014
Country
China
Email Address
exploiture@dpyy.com.cn